Phase 3 topline
Primary completion of Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
SRRK · Scholar Rock Holding Corp · Apitegromab · Spinal Muscular Atrophy
Sources and detail
- Float
- $1B–$5B
- Stake
- Research for this company needs an account. The sample companies are fully interactive without one.
- Runway vs event
- Covers the event
- Financing
- No financing filing in the period covered.
- Specialist holders
- No specialist 13F quarter has been read for this issuer.
- Insider net 90d
- No open-market insider transaction was filed in the window.
What happened
Ahead of its window
The stated window has not opened yet.
Sources (2)
- ClinicalTrials.gov · NCT05626855
clinicaltrials gov · published 2026-09-01 · retrieved 2026-09-21
“primaryCompletionDateStruct: {"date": "2026-11-01", "type": null}”
- ClinicalTrials.gov · NCT05626855
clinicaltrials gov · retrieved 2026-09-22
“primaryCompletionDateStruct: {"date": "2026-11-01", "type": "ESTIMATED"}”
Research
This event is not joined to a researched indication.
Research date unknown
Market
Market linking is switched off.
Quotes elsewhere
This desk holds no price. These go to the venues that publish one.
Runway
Cash to 2050-11-27 at the last reported burn; the event window ends 2026-11-01.
What counts as each outcome
Resolved by the sponsor's topline disclosure of the trial's primary endpoint: met with statistical significance is success; missed is failure; co-primary endpoints split, or significance reached only in a pre-specified subgroup, is mixed.
Event row last changed 2026-09-22 · filing signals evaluated 2026-09-22
What changed on this event
- — · created · event · — → Primary completion of Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab · clinicaltrials_gov-candidate
- — · status · review_state · pending → published · verified against live ClinicalTrials.gov record; primary completion date matches
- — · source added · sources · — → https://clinicaltrials.gov/study/NCT05626855 · verified against live ClinicalTrials.gov record; primary completion date matches
This is a dated event and its evidence, not a forecast of its outcome. No price, implied move or market probability is collected or shown anywhere on this page.
